Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic Constipation
Status:
Completed
Trial end date:
2016-09-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of prucalopride 2 mg, given orally once
daily for 12 weeks, in combination with PEG or lactulose, in treatment of women with Chronic
Constipation (CC) in whom laxatives fail to provide adequate relief, as measured by the
percentage of subjects with a weekly average increase of 1 or more spontaneous complete bowel
movements (SCBMs) (responders) during the 12-week treatment phase as compared to the
baseline.